116 related articles for article (PubMed ID: 36189579)
1. IFNγ-IL-17-IL-22+CD4+ subset and IL-22-producing cells in tumor draining lymph nodes of patients with breast cancer.
Salmanpour A; Rezaeifard S; Kiani R; Tahmasebi S; Faghih Z; Erfani N
Breast Dis; 2022; 41(1):383-390. PubMed ID: 36189579
[TBL] [Abstract][Full Text] [Related]
2. Determination of a CD4
Jafarinia M; Mehdipour F; Hosseini SV; Ghahramani L; Hosseinzadeh M; Ghaderi A
Tumour Biol; 2016 Nov; 37(11):14659-14666. PubMed ID: 27619682
[TBL] [Abstract][Full Text] [Related]
3. IL-17 and IL-4 producing CD8+ T cells in tumor draining lymph nodes of breast cancer patients: positive association with tumor progression.
Faghih Z; Rezaeifard S; Safaei A; Ghaderi A; Erfani N
Iran J Immunol; 2013 Dec; 10(4):193-204. PubMed ID: 24375061
[TBL] [Abstract][Full Text] [Related]
4. Memory CD4
Vahidi Y; Faghih Z; Talei AR; Doroudchi M; Ghaderi A
Cell Oncol (Dordr); 2018 Feb; 41(1):1-11. PubMed ID: 28994018
[TBL] [Abstract][Full Text] [Related]
5. Expression of Interleukin-21 and Interleukin-21 receptor in lymphocytes derived from tumor-draining lymph nodes of breast cancer.
Balouchi-Anaraki S; Mohammadsadeghi S; Norouzian M; Rasolmali R; Talei AR; Mehdipour F; Ghaderi A
Breast Dis; 2022; 41(1):373-382. PubMed ID: 36189580
[TBL] [Abstract][Full Text] [Related]
6. Immune profiles of CD4+ lymphocyte subsets in breast cancer tumor draining lymph nodes.
Faghih Z; Erfani N; Haghshenas MR; Safaei A; Talei AR; Ghaderi A
Immunol Lett; 2014; 158(1-2):57-65. PubMed ID: 24326038
[TBL] [Abstract][Full Text] [Related]
7. Cytokine profile of CD4
Niakan A; Faghih Z; Talei AR; Ghaderi A
Mol Immunol; 2019 Dec; 116():90-97. PubMed ID: 31630080
[TBL] [Abstract][Full Text] [Related]
8. CD8-positive memory T cells in tumor-draining lymph nodes of patients with breast cancer.
Vahidi Y; Bagheri M; Ghaderi A; Faghih Z
BMC Cancer; 2020 Mar; 20(1):257. PubMed ID: 32228503
[TBL] [Abstract][Full Text] [Related]
9. CD8+ T Lymphocyte Subsets in Bladder Tumor Draining Lymph Nodes.
Faghih Z; Shobeiri SS; Ariafar A; Sarkarian M; Zeighami S; Nazari N; Abbasi-Sarvak S; Erfani N
Iran J Immunol; 2016 Dec; 13(4):237-248. PubMed ID: 27999236
[TBL] [Abstract][Full Text] [Related]
10. The significance of cytokine-producing B cells in breast tumor-draining lymph nodes.
Mehdipour F; Razmkhah M; Faghih Z; Bagheri M; Talei AR; Ghaderi A
Cell Oncol (Dordr); 2019 Jun; 42(3):381-395. PubMed ID: 30850950
[TBL] [Abstract][Full Text] [Related]
11. GM-CSF-producing lymphocytes in tumor-draining lymph nodes of patients with bladder cancer.
Ariafar A; Zareinejad M; Soltani M; Vahidi Y; Faghih Z
Eur Cytokine Netw; 2021 Mar; 32(1):1-7. PubMed ID: 34346868
[TBL] [Abstract][Full Text] [Related]
12. [Tumor infiltrating regulatory T cells in human breast cancer and associated draining lymph nodes: an in-situ analysis].
Wang HY; Shi QF; Sun Y; He JJ; Wang YL
Zhonghua Bing Li Xue Za Zhi; 2013 Feb; 42(2):95-100. PubMed ID: 23710915
[TBL] [Abstract][Full Text] [Related]
13. Significance of TIM-3 expression by CD4
Shariati S; Ghods A; Zohouri M; Rasolmali R; Talei AR; Mehdipour F; Ghaderi A
Mol Immunol; 2020 Dec; 128():47-54. PubMed ID: 33068833
[TBL] [Abstract][Full Text] [Related]
14. TNFR2 but not TNFR1 is the main TNFR expressed by B and T lymphocytes in breast cancer draining lymph nodes.
Ghods A; Ghaderi A; Shariat M; Talei AR; Mehdipour F
Immunol Lett; 2019 May; 209():36-44. PubMed ID: 30910714
[TBL] [Abstract][Full Text] [Related]
15. NK, NKT and Invariant-NKT Cells in Tumor Draining Lymph Nodes of Patients with Breast Cancer.
Rezaeifard S; Safaei A; Talei A; Faghih Z; Erfani N
Iran J Immunol; 2019 Dec; 16(4):291-298. PubMed ID: 31885006
[TBL] [Abstract][Full Text] [Related]
16. Profile of immune cells in axillary lymph nodes predicts disease-free survival in breast cancer.
Kohrt HE; Nouri N; Nowels K; Johnson D; Holmes S; Lee PP
PLoS Med; 2005 Sep; 2(9):e284. PubMed ID: 16124834
[TBL] [Abstract][Full Text] [Related]
17. Granzyme B production by activated B cells derived from breast cancer-draining lymph nodes.
Arabpour M; Rasolmali R; Talei AR; Mehdipour F; Ghaderi A
Mol Immunol; 2019 Oct; 114():172-178. PubMed ID: 31357083
[TBL] [Abstract][Full Text] [Related]
18. Increased intratumoral IL-22-producing CD4(+) T cells and Th22 cells correlate with gastric cancer progression and predict poor patient survival.
Zhuang Y; Peng LS; Zhao YL; Shi Y; Mao XH; Guo G; Chen W; Liu XF; Zhang JY; Liu T; Luo P; Yu PW; Zou QM
Cancer Immunol Immunother; 2012 Nov; 61(11):1965-75. PubMed ID: 22527243
[TBL] [Abstract][Full Text] [Related]
19. [Clinical significance of CD4+ CD25+ regulatory T-cells detection in tumor-draining lymph nodes of nonsmall cell lung cancer patients].
Su YJ; Ren K; Li H; Ren XB; Wang CL
Zhonghua Zhong Liu Za Zhi; 2007 Dec; 29(12):922-6. PubMed ID: 18478932
[TBL] [Abstract][Full Text] [Related]
20. Distribution of CD4+CD25high regulatory T-cells in tumor-draining lymph nodes in patients with gastric cancer.
Kawaida H; Kono K; Takahashi A; Sugai H; Mimura K; Miyagawa N; Omata H; Ooi A; Fujii H
J Surg Res; 2005 Mar; 124(1):151-7. PubMed ID: 15734494
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
